Houston (1)

Kidney Medullary Carcinoma (1)

Loss of INI 1 Protein Expression (1)

Stage III Renal Cell Cancer AJCC v8 (1)

Stage IV Renal Cell Cancer AJCC v8 (1)

Active, not recruiting (1)

phase 2 (1)

M.D. Anderson Cancer Center (1)

National Cancer Institute (NCI) (1)

ipilimumab (1)

nivolumab (1)

biological (1)

Other (1)

Interventional (1)

loss of ini 1 protein expression

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Active, not recruiting

Sep 22, 2022